Briançon D, Meunier P J
Hôpital Reine Hortense, Aix-les-Bains.
Rev Fr Gynecol Obstet. 1987 Dec;82(12):713-8.
Non hormonal treatments for postmenopausal osteoporosis are curative and preventive treatments that do not call for sex hormones. Curative treatments aim to reduce the frequency of relapsing vertebral fractures and they mainly consist in sodium fluoride (50 mg/day) combined with Calcium (1 g element/day). Preventive treatments are intended to prevent the occurrence of vertebral fractures. They consist in calcium, physical exercise, vitamin D and calcitonin. Calcium and physical exercise are simple and inexpensive means which may be convenient for every woman, with no need for any preselection, and which can be combined together very well. They are however less effective than estrogen--progestogen combination. Vitamin D and its metabolites do not seem to be helpful for prevention of postmenopausal osteoporosis. Calcitonin is likely to offer good prospects for the future, because it has no major side effect and is able to restrain bone loss. Its use however will be dependent on a change in its mode of administration (intranasal), and a lowering of its cost (bacterial synthesis?). Lastly, a great effort has to be directed towards a thorough knowledge of osteoporosis risk factors, in order to carry out their elimination and the screening of high risk female patients.
绝经后骨质疏松症的非激素治疗是不涉及性激素的治疗和预防方法。治疗性治疗旨在减少椎体骨折复发的频率,主要包括氟化钠(50毫克/天)与钙(1克元素/天)联合使用。预防性治疗旨在预防椎体骨折的发生。它们包括钙、体育锻炼、维生素D和降钙素。钙和体育锻炼是简单且廉价的方法,对每个女性来说都很方便,无需任何预先筛选,并且可以很好地结合在一起。然而,它们的效果不如雌激素 - 孕激素联合治疗。维生素D及其代谢产物似乎对预防绝经后骨质疏松症没有帮助。降钙素未来可能有很好的前景,因为它没有重大副作用,并且能够抑制骨质流失。然而,它的使用将取决于其给药方式的改变(鼻内给药)以及成本的降低(细菌合成?)。最后,必须大力致力于全面了解骨质疏松症的危险因素,以便消除这些因素并筛查高危女性患者。